Massachusetts Financial Services Co. MA grew its position in Novo Nordisk A/S (NYSE:NVO – Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and ...

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

Benchmark Genetics is a leading aquaculture genetics business with great potential, and Novo Holdings is an excellent owner ...

Adcendo is adding $135 million to its arsenal, money that will go toward launching several antibody-drug conjugate (ADC) ...

The Sheffield, England-based company is selling Benchmark Genetics Ltd and Benchmark Genetics Norway AS to Starfish Bidco AS, a wholly owned subsidiary of Novo Holdings AS, for an enterprise value of ...

Attention then turns to US data as an abbreviated trading week across the Atlantic progresses. The personal consumption expenditures inflation gauge is released on Wednesday, as it the latest initial ...

Novo Holdings, the controlling shareholder of Novo Nordisk (NVO), is slated to received unconditional EU antitrust approval for its proposed ...

Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug ...

EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent, a ...

The European Commission is expected to give unconditional approval for the $16.5 billion purchase of Catalent (NYSE: CTLT) as ...